We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Platelet-Rich Plasma Reduces Sternal Wound Infections

By HospiMedica International staff writers
Posted on 03 Jun 2015
Print article
A new study shows that using platelet–rich plasma (PRP) inside the sternotomy wound can significantly reduce the occurrence of infections following cardiac surgery.

Researchers at Magna Graecia University (Catanzaro, Italy) and Pugliese Ciaccio Hospital (Catanzaro, Italy) conducted a study involving 1,093 consecutive patients who underwent cardiac surgery through median sternotomy between January 2007 and January 2012 to evaluate the effectiveness of PRP applied inside the sternotomy wound in reducing the effect of sternal wound infections, both superficial and deep. Antibiotic prophylaxis protocols remained unchanged throughout the study.

The study group included those who received the PRP applied inside the sternotomy wound before closure; the control group included patients who received a median sternotomy, but without the application of PRP. The results showed that the occurrence of deep sternal wound infections was significantly higher in the control group (1.5%) than in the study group (0.2%). In addition, superficial sternal wound infection rates were significantly higher in the control group than in the study group (2·8% versus 0.5%, respectively). The study was published on May 21, 2015, in International Wound Journal.

“Despite the large choice of wide-spectrum antibiotic therapy, deep sternal wound infection following cardiac surgery is a life-threatening complication worldwide,” concluded lead author Giuseppe Serraino, MD, of the cardiac surgery unit at Magna Graecia University, and colleagues. “The use of PRP can significantly reduce the occurrence of deep sternal wound infection and superficial sternal wound infections in cardiac surgery.”

PRP is blood plasma that has been enriched with platelets. The preparation process involves the collection of the patient's whole blood, which undergoes centrifugation to separate the PRP aliquot from platelet-poor plasma and red blood cells; the process concentrates the platelets roughly five-fold. As a concentrated source of autologous platelets, PRP contains several different growth factors and other cytokines that stimulate healing of bone and soft tissue. PRP has been investigated and used as a clinical tool for several types of medical treatments, including nerve injury, tendinitis, osteoarthritis, bone repair and regeneration, and plastic and oral surgery.

Related Links:

Magna Graecia University
Pugliese Ciaccio Hospital


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Ultrasound System
Voluson Signature 18

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.